These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21392911)

  • 1. MRI in the assessment of non ischemic myocardial diseases.
    De Smet K; Verdries D; Tanaka K; De Mey J; De Maeseneer M
    Eur J Radiol; 2012 Jul; 81(7):1546-8. PubMed ID: 21392911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement.
    Jackson E; Bellenger N; Seddon M; Harden S; Peebles C
    Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
    Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
    Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease.
    Moraes GL; Higgins CB; Ordovas KG
    J Thorac Imaging; 2013 Mar; 28(2):84-92; quiz 93-5. PubMed ID: 23422782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
    Mahrholdt H; Wagner A; Judd RM; Sechtem U; Kim RJ
    Eur Heart J; 2005 Aug; 26(15):1461-74. PubMed ID: 15831557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging.
    Petersen SE; Selvanayagam JB; Wiesmann F; Robson MD; Francis JM; Anderson RH; Watkins H; Neubauer S
    J Am Coll Cardiol; 2005 Jul; 46(1):101-5. PubMed ID: 15992642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of MRI in the assessment of the cardiac anatomy and function].
    Paciorek A; Urbanik A; Brzozowska-Czarnek A; Paciorek J; Herman-Sucharska I
    Przegl Lek; 2010; 67(4):306-13. PubMed ID: 20687365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyopathies (hypertrophy and failure): what can offer cardiac magnetic resonance imaging?
    Silvera S; Strach K; Bogaert J; Sommer T; Vignaux O
    Presse Med; 2011 Sep; 40(9 Pt 2):e425-36. PubMed ID: 21795013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed-enhancement magnetic resonance imaging in patients with clinically suspected stress cardiomyopathy (Tako-tsubo).
    Muellerleile K; Lund G; Groth M; Barmeyer A; Sultan A; Heitzer T; Willems S; Adam G; Meinertz T; Koester R
    Rofo; 2010 Jan; 182(1):29-35. PubMed ID: 19676014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of MRI in the diagnosis and management of cardiomyopathies.
    Rochitte CE; Tassi EM; Shiozaki AA
    Curr Cardiol Rep; 2006 Feb; 8(1):44-52. PubMed ID: 16507236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A
    Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies.
    Wassmuth R
    Minerva Cardioangiol; 2009 Aug; 57(4):511-20. PubMed ID: 19763072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging for characterizing myocardial diseases.
    Saeed M; Liu H; Liang CH; Wilson MW
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1395-1414. PubMed ID: 28364177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.